This Article Abstract Full Text Full Text (PDF) View Study Participants Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Garcia, D. A. Articles by Hylek, E. M. Search for Related Content PubMed PubMed Citation Articles by Garcia, D. A. Articles by Hylek, E. M.

The Risk of Hemorrhage Among Patients With Warfarin-Associated Coagulopathy

David A. Garcia, MD^_*,_*, Susan Regan, PhD, Mark Crowther, MD and Elaine M. Hylek, MD, MPH

^_* Department of Medicine, University of New Mexico, Albuquerque, New Mexico
Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Department of Medicine, General Internal Medicine Research Unit, Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts

View larger version (14K): [in a new window]   Figure 1 Box and whisker plot of the next consecutive international normalized ratio (INR) value obtained after the index INR, plotted by the number of days between the index and next INR date. The boxes delineate the interquartile range, extending from the 25th to the 75th percentile. The bar across the middle of the box represents the median. The whiskers reach to the most extreme value that is within 1.5 times the interquartile range beyond the box. Points more extreme than that are individually plotted. Patients for whom vitamin K use was documented and patients whose warfarin therapy was not interrupted have been excluded from this analysis.